News on ZIVIC LABORATORIES INC. from BioPortfolio.com http://www.BioPortfolio.com Consolidated ZIVIC LABORATORIES INC. news from BioPortfolio.com Wed, 10 Feb 2010 00:45:06 GMT en Antares Pharma, Inc. - Financial And Strategic Analysis Review - New Report Publishedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034416&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZIVIC%20LABORATORIES%20INC.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034416&THISHREF=http://c.moreover.com/click/here.pl%3fz2535781097%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034416&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZIVIC%20LABORATORIES%20INC.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034416&THISHREF=http://c.moreover.com/click/here.pl%3fz2535781097%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comOfficialWire: UC Riverside licenses technology to OlFactor Laboratories, Inc.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036440&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZIVIC%20LABORATORIES%20INC.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036440&THISHREF=http://c.moreover.com/click/here.pl%3fz2536619155%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036440&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZIVIC%20LABORATORIES%20INC.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036440&THISHREF=http://c.moreover.com/click/here.pl%3fz2536619155%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comResearch & Development: Updates for BioElectronics (OTC:BIEL), Borealis (OTC:BOREF), Charles River Laboratories (NYSE:CRL)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035380&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZIVIC%20LABORATORIES%20INC.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035380&THISHREF=http://c.moreover.com/click/here.pl%3fz2536218755%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035380&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZIVIC%20LABORATORIES%20INC.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035380&THISHREF=http://c.moreover.com/click/here.pl%3fz2536218755%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comLos Angeles Chronicle: UDATE 1-NeurogesX sees 'mid-tier' pain-patch pricehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032335&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZIVIC%20LABORATORIES%20INC.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032335&THISHREF=http://c.moreover.com/click/here.pl%3fz2534607077%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032335&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZIVIC%20LABORATORIES%20INC.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032335&THISHREF=http://c.moreover.com/click/here.pl%3fz2534607077%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSharenet: Prometheus Makes Deal to Sell Skin and Kidney Cancer Drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031275&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZIVIC%20LABORATORIES%20INC.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031275&THISHREF=http://c.moreover.com/click/here.pl%3fz2534115750%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031275&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZIVIC%20LABORATORIES%20INC.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031275&THISHREF=http://c.moreover.com/click/here.pl%3fz2534115750%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSan Diego Business Journal: EU expected to clear Abbott, Solvay deal - sourceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031117&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZIVIC%20LABORATORIES%20INC.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031117&THISHREF=http://c.moreover.com/click/here.pl%3fz2534002874%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031117&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZIVIC%20LABORATORIES%20INC.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031117&THISHREF=http://c.moreover.com/click/here.pl%3fz2534002874%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCNN Money: CORRECTED-EU expected to clear Abbott, Solvay deal - sourceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031081&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZIVIC%20LABORATORIES%20INC.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031081&THISHREF=http://c.moreover.com/click/here.pl%3fz2533982145%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031081&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZIVIC%20LABORATORIES%20INC.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031081&THISHREF=http://c.moreover.com/click/here.pl%3fz2533982145%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInteractive Investor: CORRECTED-EU expected to clear Abbott, Solvay deal - sourceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031071&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZIVIC%20LABORATORIES%20INC.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031071&THISHREF=http://c.moreover.com/click/here.pl%3fz2533974847%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031071&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZIVIC%20LABORATORIES%20INC.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031071&THISHREF=http://c.moreover.com/click/here.pl%3fz2533974847%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: EU expected to clear Abbott, Solvay deal - sourceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030141&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZIVIC%20LABORATORIES%20INC.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030141&THISHREF=http://c.moreover.com/click/here.pl%3fz2533461787%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030141&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZIVIC%20LABORATORIES%20INC.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030141&THISHREF=http://c.moreover.com/click/here.pl%3fz2533461787%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInteractive Investor: EU expected to clear Abbott, Solvay deal - sourceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030086&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZIVIC%20LABORATORIES%20INC.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030086&THISHREF=http://c.moreover.com/click/here.pl%3fz2533432435%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030086&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZIVIC%20LABORATORIES%20INC.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030086&THISHREF=http://c.moreover.com/click/here.pl%3fz2533432435%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: Sagent Pharmaceuticals Announces FDA Approval of Labetalol Hydrochloride Injection, USPhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030159&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZIVIC%20LABORATORIES%20INC.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030159&THISHREF=http://c.moreover.com/click/here.pl%3fz2533474020%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030159&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZIVIC%20LABORATORIES%20INC.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030159&THISHREF=http://c.moreover.com/click/here.pl%3fz2533474020%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Bio-Rad Laboratories, Inc. Announces Completion of Exchange Offerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018274&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZIVIC%20LABORATORIES%20INC.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018274&THISHREF=http://c.moreover.com/click/here.pl%3fz2525552272%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018274&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZIVIC%20LABORATORIES%20INC.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018274&THISHREF=http://c.moreover.com/click/here.pl%3fz2525552272%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Bio-Rad Laboratories, Inc. Announces Completion of Exchange Offerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018263&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZIVIC%20LABORATORIES%20INC.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018263&THISHREF=http://c.moreover.com/click/here.pl%3fz2525547731%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018263&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZIVIC%20LABORATORIES%20INC.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018263&THISHREF=http://c.moreover.com/click/here.pl%3fz2525547731%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Carl Icahn on CEOs and Boards of Directorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018627&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZIVIC%20LABORATORIES%20INC.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018627&THISHREF=http://c.moreover.com/click/here.pl%3fz2525838492%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018627&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZIVIC%20LABORATORIES%20INC.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018627&THISHREF=http://c.moreover.com/click/here.pl%3fz2525838492%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGuru Focus: Hemispherx Biopharma Appoints Two Senior Pharma Executives to Key...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013662&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZIVIC%20LABORATORIES%20INC.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013662&THISHREF=http://c.moreover.com/click/here.pl%3fz2523799555%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013662&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ZIVIC%20LABORATORIES%20INC.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013662&THISHREF=http://c.moreover.com/click/here.pl%3fz2523799555%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: